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a  b  s  t  r  a  c  t
Primary  cardiac  sarcomas  are  rare.  A 63-year-old  woman  presented  with  progressive  symptoms  of
fatigue,  palpitations,  and  dyspnea.  Transthoracic  echocardiography  detected  a mass  in the  left  atrium,
ﬁxed  and  probably  attached  to the  interatrial  septum  suggestive  of  myxoma.  Transesophageal  echocar-
diography  conﬁrmed  the existence  of  a large  lobulated  mass in  the left  atrium  measuring  45  mm  × 25  mm
in diameter.  Subsequent  cardiac  magnetic  resonance  imaging  showed  a mass  of  heterogeneous  appear-
ance,  with broad  base  of  implantation  on  the  posterior  wall  of the left atrium.  The  extension  study  with
multidetector  computed  tomography  showed  superﬁcial  inﬁltration  of the atrial  wall,  without  involve-
ment  of the  mitral  valve  or pulmonary  veins  and  no extension  to other  extracardiac  structures.  The  patient
underwent  surgery  resecting  a bilobed  mass,  smooth  and  yellowish,  strongly  attached  to  the  posterioragnetic resonance imaging wall of  left  atrium.  The  pathologic  study  was  consistent  with  the diagnosis  of  myxoﬁbrosarcoma.
<Learning  objective:  Primary  cardiac  tumors  are  among  the  most  challenging  disease  entities  to diagnose
because  of their  rarity  and  highly  variable  and usually  nonspeciﬁc  clinical  presentation.  Although  the
deﬁnitive  diagnosis  of  a cardiac  tumor,  whether  benign  or malignant  and  the  tumor  type  is  provided  by
histological  examination,  imaging  techniques  are  essential  for conﬁrming  the  existence  of  a cardiac  mass
and characterizing  the  tumor  before  obtaining  a sample  for pathologic  examination.>
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Primary tumors of the heart are rare, with a reported preva-
ence of 0.001–0.03% in autopsy series [1]. About 75% of all primary
ardiac tumors are regarded as benign neoplasms, with cardiac
yxoma accounting for at least half of them. Of the remaining 25%,
hat are considered to be malignant neoplasms, the majority are
arcomas, angiosarcoma being the most common variety [2].
Myxoﬁbrosarcoma is a tumor of mesenchymal origin that occurs
ost commonly in the extremities of the elderly [3]. However, pri-
ary myxoﬁbrosarcoma rarely arises in the heart, with only a few
ases reported in international literature [4,5]. Myxoﬁbrosarcoma
f the heart may  involve any of the 4 cardiac chambers, but most
requently affects the left atrium. It may  arise from myocardium
r valve tissue. Low-grade tumors invade local tissue including
alvular structures. High-grade tumors also invade locally, but
ay  also metastasize to contiguous and distant sites. Left atrial
yxoﬁbrosarcoma may  simulate left atrial myxoma in its clinical
resentation.
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Case report
A 63-year-old woman  with a history of hypertension and asthma
presented with progressive symptoms of fatigue, palpitations, and
dyspnea. Cardiac auscultation exhibited pure heart tones with no
murmurs or added sounds. The rest of the physical examination as
well as electrocardiogram, chest radiography, and analytics were
normal.
Transthoracic echocardiography detected a mass in the left
atrium, ﬁxed and probably attached to the interatrial septum sug-
gestive of myxoma. Transesophageal echocardiography conﬁrmed
the existence of a large lobulated mass in left atrium measuring
45 mm × 25 mm in diameter (Fig. 1). The insertion site was  large,
poorly deﬁned by this technique, up to the roof of the left atrium.
The mass had diastolic protrusion through the mitral valve leaﬂets
without being obstructive and showed heterogeneous echo con-
trast uptake.
A subsequent cardiac magnetic resonance imaging (MRI)
showed a mass of heterogeneous appearance, with broad base of
implantation on the posterior wall of the left atrium. The mass
showed isointense signal relative to the heart muscle on T1-
weighted sequences, suggesting the absence of fat or hemorrhage,
and markedly hyperintense on STIR sequences, so it was  a struc-
ture with a high content of water (Fig. 2). In the ﬁrst-pass perfusion
vier Ltd. All rights reserved.
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Fig. 1. (A) Transthoracic echocardiogram apical four-chamber view showing a large mas
shows  a lobulated mass protruding through the mitral valve. LV, left ventricle; RV, right v
Fig. 2. Cardiac magnetic resonance imaging. (A) STIR sequence axial view showing
the  mass strongly hyperintense relative to the myocardium. (B) Delayed enhance-
ment contrast sequence shows the heterogeneous appearance of the mass with
central areas of necrosis.s that occupies almost the entire left atrium. (B) Transesophageal echocardiogram
entricle; RA, right atrium.
sequence the mass was  highly perfused. Delayed enhancement
sequences showed a central hypointense zone, suggesting intra-
tumoral necrotic areas surrounded by foci of increased uptake.
A noninvasive coronary study with multidetector computed
tomography (MDCT) was  also performed before surgery, the result
of which was normal. In addition, the mass was visualized attached
to the posterior wall of the left atrium, presenting lower attenuation
than the myocardium, with heterogeneous zones inside (Fig. 3). The
extension study showed superﬁcial inﬁltration of the atrial wall,
without involvement of the mitral valve or pulmonary veins and
no extension to other extracardiac structures.
The patient underwent surgery observing a bilobed mass of
5 cm × 3 cm,  smooth and yellowish, strongly attached to the pos-
terior wall of left atrium. The whole mass tumor and its base
of implantation on the atrial wall were resected (Fig. 4). The
patient did well postoperatively, being discharged 8 days after
surgery.
The pathologic study found that the tumor consisted of spindle
or stellate morphology cells which adopted a diffuse pattern, some-
times in a swirling shape. There were areas with marked cytologic
atypia and a high number of mitosis and areas of focal necro-
sis (Fig. 5). Immunohistochemistry showed negativity for CD34,
CD31, and calretinin. This was consistent with the diagnosis of
myxoﬁbrosarcoma. Pathology conﬁrmed that the atrial wall was
superﬁcially inﬁltrated but the borders of the surgical piece were
clean.
The entire mass had been completely excised, the borders were
not affected, and the extension study was negative, so initially
she did not receive any adjuvant treatment. Fourteen months after
surgery, an echocardiographic control revealed a recurrence of the
tumor in the same location, which was  conﬁrmed by cardiac MRI
and MDCT. A new surgery was  rejected and the patient started on
chemotherapy treatment with ifosfamide and adriamycin, achiev-
ing the disappearance of the tumor on imaging tests. Sixteen
months later, she experienced a new recurrence of the tumor,
newly receiving several chemotherapy cycles with ifosfamide. The
tumor decreased in size but did not disappear. Forty-six months
after diagnosis, the patient is alive with few symptoms of the dis-
ease.
DiscussionPrimary cardiac tumors are among the most challenging dis-
ease entities to diagnose because of their rarity and highly variable
and usually nonspeciﬁc clinical presentation. Although the deﬁni-
tive diagnosis of a cardiac tumor, whether benign or malignant and
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Fig. 3. Cardiac multidetector computed tomography. (A) Oblique four-chamber view showing the big mass in the left atrium without affecting the pulmonary venous
drainage.  (B) Oblique two-chamber view shows the mass inﬁltrating the posterior wall of the atrium, which receives its vascular supply.
Fig. 4. Surgery pictures. (A) View of the mass after performing the left atriotomy. (B) Bilobed mass of 3 cm × 5 cm in diameter once resected.
Fig. 5. Pathological study. (A) Tumor is composed of myxoid cells adopting a diffuse pattern with some larger cells, alternating with zones of necrosis. (B) At higher
magniﬁcation these cells are large with dense cytoplasm, abundant and irregular nucleus, chromatin rough and frequent mitotic ﬁgures (arrows).
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he tumor type is provided by histological examination, imaging
echniques are essential for conﬁrming the existence of a cardiac
ass and characterizing the tumor before obtaining a sample for
athologic examination [6].
Echocardiography is the imaging technique most commonly
sed as a ﬁrst approximation for the diagnosis of cardiac tumors,
or its speed, high availability, and low cost. It can identify the
ocation of the mass, its insertion site, size, shape, and mobility,
n addition to detecting the presence of associated hemodynamic
lterations [7]. However, it has several limitations, mainly resulting
rom problems of acoustic window and a relatively narrow ﬁeld of
iew [8].
Cardiac MRI  offers several advantages over echocardiography
n the study of cardiac tumors, such as the characterization of
esion composition (fat, cyst, ﬁbrosis, calcium, etc.), the deﬁnition
f myocardial involvement, the study of their vascularization, the
ssessment of the inﬁltration grade, and the extension to extracar-
iac structures by providing a larger ﬁeld of exploration. Therefore
t is considered the preferred technique in the detection and char-
cterization of cardiac tumors [9].
Cardiac MDCT is also an appropriate technique for the character-
zation of cardiac tumors, but it is particularly useful for assessing
he degree of local invasion and spread to adjacent structures and
o detect metastatic lesions [10].
In this case, because of the location and type of mass, the most
ikely diagnosis was atrial myxoma. However, its large size, broad
ase of implantation in the posterior wall of the atrium, hetero-
eneous appearance with necrotic areas inside, and great vascular-
zation were more characteristic features of malignant tumors, so it
[gy Cases 7 (2013) e164–e167 e167
was not possible to rule out a possible sarcomatous etiology, which
was subsequently conﬁrmed on histologic examination.
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